Am Soc Clin Oncol Educ Book

• 

  Publication Venue For

  • Overcoming Resistance to Targeted Therapies in Gastrointestinal Cancers: Progress to Date and Progress to Come..  40:161-173. 2020
  • What's the Price? Toxicities of Targeted Therapies in Breast Cancer Care..  40:55-70. 2020
  • Optimizing Cardiovascular Health in Patients With Cancer: A Practical Review of Risk Assessment, Monitoring, and Prevention of Cancer Treatment-Related Cardiovascular Toxicity..  40:1-15. 2020
  • The Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis..  40:1-8. 2020
  • Financial Toxicity and Equitable Access to Clinical Trials..  39:11-18. 2019
  • "How Much Time Do I Have?": Communicating Prognosis in the Era of Exceptional Responders..  38:787-794. 2018
  • Complexity of Delivering Precision Medicine: Opportunities and Challenges..  38:998-1007. 2018
  • Multidisciplinary Management of Oligometastatic Soft Tissue Sarcoma..  38:939-948. 2018
  • Supportive Care in Lung Cancer: Improving Value in the Era of Modern Therapies..  38:716-725. 2018
  • Where We Stand With Immunotherapy in Colorectal Cancer: Deficient Mismatch Repair, Proficient Mismatch Repair, and Toxicity Management..  38:239-247. 2018
  • How Should We Intervene on the Financial Toxicity of Cancer Care? One Shot, Four Perspectives..  37:35-39. 2017
  • Systemic Therapy for Non-Clear Cell Renal Cell Carcinoma..  37:337-342. 2017
  • Discussing the Evidence for Upstream Palliative Care in Improving Outcomes in Advanced Cancer..  35:e534-e538. 2016
  • Immunotherapy and Checkpoint Inhibitors in Recurrent and Metastatic Head and Neck Cancer..  35:e277-e282. 2016
  • Treatment of Lung Cancer in Medically Compromised Patients..  35:e484-e491. 2016
  • Tumor Heterogeneity and Therapeutic Resistance..  35:e585-e593. 2016
  • Surgery or ablative radiotherapy for breast cancer oligometastases..  e8-15. 2015
  • Accelerated aging among cancer survivors: from pediatrics to geriatrics..  e423-e430. 2014
  • Can we maximize both value and quality in gynecologic cancer care? A work in progress..  e268-e275. 2014
  • Models of cancer survivorship health care: moving forward..  205-213. 2014
  • Biomarkers and correlative endpoints for immunotherapy trials. 2013
  • Mammographic density: intersection of science, the law, and clinical practice. 2013
  • The ethics of health information technology in oncology: emerging isssues from both local and global perspectives..  136-142. 2013
  • Thrombosis and cancer: emerging data for the practicing oncologist. 2013